This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Exploring the Innovations of Inventor Zuzana Valnickova
Introduction
Zuzana Valnickova, based in Durham, NC, is a notable inventor recognized for her significant contributions to medical diagnostics. Her work focuses on innovative methods to improve the detection of prostate-specific antigen (PSA), a vital biomarker in screening for prostate-related diseases.
Latest Patents
Zuzana Valnickova holds one patent titled "Method of detecting prostate specific antigen." This innovative method involves detecting the presence of an N-terminal activation peptide of PSA in a biological sample. It is designed to screen for or diagnose disease states associated with increased levels of secreted prostate-specific antigen, presenting a potential breakthrough in prostate healthcare.
Career Highlights
Valnickova's career has been marked by her dedication to advancing medical research. She is currently affiliated with Duke University, where she continues to engage in research that seeks to enhance diagnostic techniques and improve patient outcomes. Her work showcases a commitment to integrating scientific innovation with practical applications in medicine.
Collaborations
Throughout her career, Zuzana Valnickova has collaborated with esteemed colleagues, including Jan J Enghild and Tim D Oury. These partnerships reflect a collaborative spirit in the scientific community, fostering an environment that leads to groundbreaking discoveries and innovations.
Conclusion
In summary, Zuzana Valnickova stands out as an influential figure in the realm of medical diagnostics. Her patent on PSA detection exemplifies the intersection of technology and healthcare, showcasing the important role inventors play in improving lives through innovation. Her contributions continue to pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
